Vaxxas opens nation’s first needle-free vaccine manufacturing site
Manufacturer's Monthly
JUNE 18, 2023
Australian biotechnology company Vaxxas , in partnership with the Queensland Government, today announced the opening of its global headquarters and state-of-the-art manufacturing facility in Brisbane. The custom-built 5,500m square-metre (60,000 square feet) Vaxxas Biomedical Facility is a first-of-its-kind manufacturing site designed to support the scale-up of Vaxxas’ needle-free vaccine technology platform, the high-density microarray patch (HD-MAP), for late-stage clinical trials and first co
Let's personalize your content